Cranial nerve palsies in childhood parameningeal rhabdomyosarcoma

Pediatr Blood Cancer. 2012 Dec 15;59(7):1211-4. doi: 10.1002/pbc.24128. Epub 2012 Mar 7.

Abstract

Background: Children with parameningeal rhabdomyosarcoma (PM RMS) and cranial nerve palsy (CNP) are at risk for permanent neurologic dysfunction. Clinicians often consider the use of emergent therapies such as expedited radiation and/or corticosteroids; however, there is a paucity of information describing the natural history of CNP in PM RMS. We sought to describe the clinical features of patients with PM RMS plus associated CNP and to evaluate the patient, disease, and treatment-related factors that impacted neurologic recovery.

Methods: We conducted a retrospective review of PM RMS cases treated at the Hospital for Sick Children between 1985 and 2010.

Results: Thirty-five children were treated for PM RMS, 19 (54%) of whom presented with CNP. Children with CNP were nine times more likely to have other high-risk features (cranial base bony erosion and/or intracranial extension) at the time of presentation than children without CNP (OR 9.6, 95% CI 1.69, 54.79, P = 0.013). In addition to commencing chemotherapy, 13 patients (68%) received expedited RT and corticosteroids, four (21%) corticosteroids alone, and two (11%) received only standard chemotherapy and RT. At last follow up of the 11 survivors, neurologic recovery was complete in five (45%), partial in five (45%), and absent in one (9%).

Conclusions: In our cohort, recovery of PM RMS associated CNP was often incomplete despite multi-modal therapy. A larger cohort of patients is required to determine the utility of emergent initiation of radiation or corticosteroids. This study will facilitate the counseling of future families on the long-term neurologic recovery CNP in PM RMS.

MeSH terms

  • Child
  • Child, Preschool
  • Cranial Nerve Diseases / etiology*
  • Cranial Nerve Diseases / therapy
  • Female
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Male
  • Meningeal Neoplasms / complications*
  • Meningeal Neoplasms / therapy
  • Rhabdomyosarcoma / complications*
  • Rhabdomyosarcoma / therapy
  • Treatment Outcome